Completed
A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis - IM032-041
Aggiornato:
20 novembre, 2025
|
ClinicalTrials.gov
Sintesi in un linguaggio semplice